Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparison of Propylthiouracil vs Methimazole for Thyroid Storm in Critically Ill Patients

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.8655Source: DataRank Database

Comparison of Propylthiouracil vs Methimazole for Thyroid Storm in Critically Ill Patients is a research paper published in JAMA Network Open (2023). On theSindex it has a DataRank of 0. It has been cited 36 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access36 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 5.37)OA: goldTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Katherine L. Modzelewski ORCID,Anica C. Law ORCID,Allan J. Walkey ORCID,Elizabeth N. Pearce ORCID,Nicholas A. Bosch ORCID

Live enrichment

PubMed:37067797 PMC:PMC10111182 OpenAlex:https://openalex.org/W4366084083

NHLBI NIH HHS

Grant: K23 HL153482

NIEHS NIH HHS

Grant: K23 ES028736

National Institutes of Health

Grant: 1K23ES028736-01A1

Effects of maternal thyroid function and thyroidal disruptor exposure on pregnancy and child developmental outcomes

National Institutes of Health

Grant: 5KL2TR001411-06

Institutional Career Development

National Institutes of Health

Grant: 3UL1TR001430-05A1S2

Boston University Clinical and Translational Science Institute

FWCI

5.37

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2803923/lee_2023_oi_230275_1680890810.84907.pdf

publisherhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2803923/lee_2023_oi_230275_1680890810.84907.pdf

journalhttps://doi.org/10.1001/jamanetworkopen.2023.8655

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37067797

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10111182

Fields of Study

Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and TreatmentOphthalmology and Eye Disorders03 medical and health sciences0302 clinical medicine

MeSH Terms

AdultFemaleHumansMethimazoleMiddle AgedPropylthiouracilAntithyroid AgentsThyroid CrisisCritical IllnessHospital Mortality

Keywords

PropylthiouracilThyroid stormMedicineAntithyroid agentGraves' diseaseThyroidInternal medicinePediatricsCohort studyMethimazoleAdultAntithyroid AgentsCritical IllnessHumansFemaleHospital MortalityMiddle AgedThyroid CrisisOriginal Investigation

Sustainable Development Goals

SDG 0: Good health and well-being

Comparison of Propylthiouracil vs Methimazole for Thyroid Storm in Critically Ill Patients

FAIR Checklist

Authors (6)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)